FNBT
KDNY

FineMark National Bank & Trust’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

FineMark National Bank & Trust’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-6
Closed -$1K – 1602
2015
Q2 		$1K Buy
+6
New +$991 ﹤0.01% 1388

Other funds holding KDNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
M&T Bank
M&T Bank Buffalo, New York $34.1B AUM 29.2% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

FineMark National Bank & Trust's KDNY Position: Q3 2015 in Review

FineMark National Bank & Trust sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2015, closing a stake of 6 shares — an estimated $1K sold.

FineMark National Bank & Trust first reported a position in KDNY in Q2 2015 and held it in 1 quarter. The position peaked at $1K in Q2 2015. 76 funds tracked by Wall St. Rank hold KDNY as of Q3 2015.

  • FineMark National Bank & Trust reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • FineMark National Bank & Trust sold 6 Chinook Therapeutics, Inc. Common Stock shares in Q3 2015, an estimated $1K.
  • FineMark National Bank & Trust first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and held it in 1 quarter.
  • FineMark National Bank & Trust's Chinook Therapeutics, Inc. Common Stock position peaked at $1K in Q2 2015.
  • 76 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2015.

Based on FineMark National Bank & Trust's 13F filing for Q3 2015, filed 13 Nov 2015.